{"id":33552,"date":"2025-01-22T10:06:09","date_gmt":"2025-01-22T15:06:09","guid":{"rendered":"https:\/\/www.cancerresearch.org\/?post_type=cri_scientists&#038;p=33552"},"modified":"2025-06-13T14:27:54","modified_gmt":"2025-06-13T18:27:54","slug":"seongyeol-park-md-phd","status":"publish","type":"cri_scientists","link":"https:\/\/www.cancerresearch.org\/es\/cri-funded-scientists\/seongyeol-park-md-phd","title":{"rendered":"Seongyeol Park, MD, PhD"},"content":{"rendered":"\n<p>Seongyeol Park, MD, PhD, a biomedical scientist trained in both medical and bioinformatics techniques, is tackling the challenges of triple-negative breast cancer (TNBC) treatment. His project at the Stanford Cancer Institute leverages advanced spatial omics to explore how TNBC tumors interact with metastatic organs and respond to immune checkpoint inhibitors (ICIs). By analyzing a unique set of clinical trial specimens, Dr. Park aims to create predictive models of ICI response, which could revolutionize treatment decisions for TNBC and other metastatic cancers.&nbsp;<\/p>\n\n\n\n<p>Having previously worked as an internal medicine doctor and cancer researcher, Dr. Park\u2019s PhD in cancer genomics honed his expertise in computational oncology. His work on detecting complex cancer rearrangements and building phylogenetic models has been published in <em>Cell<\/em> and <em>Nature<\/em>, contributing significantly to our understanding of cancer evolution.&nbsp;<\/p>\n\n\n\n<p>\u00abI\u2019m focused on understanding how tumors evolve in different organs and how this affects their response to immunotherapy,\u00bb says Dr. Park. His work promises to improve cancer treatment strategies, ultimately guiding more effective and personalized approaches for metastatic cancer patients.&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Projects and Grants<\/h2>\n\n\n\n<h3 class=\"wp-block-heading\">Organ-specific Cancer-Immune Co-evolution in Metastatic Breast Cancer\u00a0<\/h3>\n\n\n\n<p>Stanford University | Breast Cancer | 2025 | Christina Curtis, PhD, and Edgar Engleman, MD<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Seongyeol Park, MD, PhD, a biomedical scientist trained in both medical and bioinformatics techniques, is tackling the challenges of triple-negative breast cancer (TNBC) treatment. His project at the Stanford Cancer Institute leverages [&hellip;]<\/p>\n","protected":false},"featured_media":33608,"template":"","tax_cancer_type":[365],"tax_grant_type":[860],"tax_award_year":[742],"tax_institutions":[513],"tax_location_states":[501],"class_list":["post-33552","cri_scientists","type-cri_scientists","status-publish","has-post-thumbnail","hentry"],"acf":{"scientist_subhead":"CRI Dr. Keith Landesman Memorial Immuno-Informatics Fellow","quote":"","scientist_last_name":"Park","show_on_landing":true,"scientist_publish_until":"20271231"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Seongyeol Park, MD, PhD - Cancer Research Institute<\/title>\n<meta name=\"description\" content=\"CRI Immuno-Informatics Postdoctoral Fellow Seongyeol Park, MD, PhD, is researching cancer-immune co-evolution in breast cancer immunotherapy.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/seongyeol-park-md-phd\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Seongyeol Park, MD, PhD - Cancer Research Institute\" \/>\n<meta property=\"og:description\" content=\"CRI Immuno-Informatics Postdoctoral Fellow Seongyeol Park, MD, PhD, is researching cancer-immune co-evolution in breast cancer immunotherapy.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/seongyeol-park-md-phd\" \/>\n<meta property=\"og:site_name\" content=\"Cancer Research Institute\" \/>\n<meta property=\"article:modified_time\" content=\"2025-06-13T18:27:54+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/02\/seongyeol-park-800x800-1.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"800\" \/>\n\t<meta property=\"og:image:height\" content=\"800\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/seongyeol-park-md-phd\",\"url\":\"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/seongyeol-park-md-phd\",\"name\":\"Seongyeol Park, MD, PhD - Cancer Research Institute\",\"isPartOf\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/seongyeol-park-md-phd#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/seongyeol-park-md-phd#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/02\/seongyeol-park-800x800-1.webp\",\"datePublished\":\"2025-01-22T15:06:09+00:00\",\"dateModified\":\"2025-06-13T18:27:54+00:00\",\"description\":\"CRI Immuno-Informatics Postdoctoral Fellow Seongyeol Park, MD, PhD, is researching cancer-immune co-evolution in breast cancer immunotherapy.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/seongyeol-park-md-phd#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/seongyeol-park-md-phd\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/seongyeol-park-md-phd#primaryimage\",\"url\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/02\/seongyeol-park-800x800-1.webp\",\"contentUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/02\/seongyeol-park-800x800-1.webp\",\"width\":800,\"height\":800,\"caption\":\"Seongyeol Park, MD, PhD\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/seongyeol-park-md-phd#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.cancerresearch.org\/es\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Seongyeol Park, MD, PhD\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cancerresearch.org\/#website\",\"url\":\"https:\/\/www.cancerresearch.org\/\",\"name\":\"Cancer Research Institute\",\"description\":\"For a World Immune to Cancer\",\"publisher\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cancerresearch.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cancerresearch.org\/#organization\",\"name\":\"Cancer Research Institute\",\"url\":\"https:\/\/www.cancerresearch.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg\",\"contentUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg\",\"width\":156,\"height\":53,\"caption\":\"Cancer Research Institute\"},\"image\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Seongyeol Park, MD, PhD - Cancer Research Institute","description":"CRI Immuno-Informatics Postdoctoral Fellow Seongyeol Park, MD, PhD, is researching cancer-immune co-evolution in breast cancer immunotherapy.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/seongyeol-park-md-phd","og_locale":"es_ES","og_type":"article","og_title":"Seongyeol Park, MD, PhD - Cancer Research Institute","og_description":"CRI Immuno-Informatics Postdoctoral Fellow Seongyeol Park, MD, PhD, is researching cancer-immune co-evolution in breast cancer immunotherapy.","og_url":"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/seongyeol-park-md-phd","og_site_name":"Cancer Research Institute","article_modified_time":"2025-06-13T18:27:54+00:00","og_image":[{"width":800,"height":800,"url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/02\/seongyeol-park-800x800-1.webp","type":"image\/webp"}],"twitter_card":"summary_large_image","twitter_misc":{"Tiempo de lectura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/seongyeol-park-md-phd","url":"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/seongyeol-park-md-phd","name":"Seongyeol Park, MD, PhD - Cancer Research Institute","isPartOf":{"@id":"https:\/\/www.cancerresearch.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/seongyeol-park-md-phd#primaryimage"},"image":{"@id":"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/seongyeol-park-md-phd#primaryimage"},"thumbnailUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/02\/seongyeol-park-800x800-1.webp","datePublished":"2025-01-22T15:06:09+00:00","dateModified":"2025-06-13T18:27:54+00:00","description":"CRI Immuno-Informatics Postdoctoral Fellow Seongyeol Park, MD, PhD, is researching cancer-immune co-evolution in breast cancer immunotherapy.","breadcrumb":{"@id":"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/seongyeol-park-md-phd#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cancerresearch.org\/cri-funded-scientists\/seongyeol-park-md-phd"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/seongyeol-park-md-phd#primaryimage","url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/02\/seongyeol-park-800x800-1.webp","contentUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/02\/seongyeol-park-800x800-1.webp","width":800,"height":800,"caption":"Seongyeol Park, MD, PhD"},{"@type":"BreadcrumbList","@id":"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/seongyeol-park-md-phd#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.cancerresearch.org\/es"},{"@type":"ListItem","position":2,"name":"Seongyeol Park, MD, PhD"}]},{"@type":"WebSite","@id":"https:\/\/www.cancerresearch.org\/#website","url":"https:\/\/www.cancerresearch.org\/","name":"Cancer Research Institute","description":"For a World Immune to Cancer","publisher":{"@id":"https:\/\/www.cancerresearch.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cancerresearch.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.cancerresearch.org\/#organization","name":"Cancer Research Institute","url":"https:\/\/www.cancerresearch.org\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg","contentUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg","width":156,"height":53,"caption":"Cancer Research Institute"},"image":{"@id":"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/"}}]}},"fimg_url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/02\/seongyeol-park-800x800-1.webp","_links":{"self":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/cri_scientists\/33552","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/cri_scientists"}],"about":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/types\/cri_scientists"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/media\/33608"}],"wp:attachment":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/media?parent=33552"}],"wp:term":[{"taxonomy":"tax_cancer_type","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/tax_cancer_type?post=33552"},{"taxonomy":"tax_grant_type","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/tax_grant_type?post=33552"},{"taxonomy":"tax_award_year","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/tax_award_year?post=33552"},{"taxonomy":"tax_institutions","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/tax_institutions?post=33552"},{"taxonomy":"tax_location_states","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/tax_location_states?post=33552"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}